0001171000-15-000108.txt : 20151124 0001171000-15-000108.hdr.sgml : 20151124 20151124153751 ACCESSION NUMBER: 0001171000-15-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151123 FILED AS OF DATE: 20151124 DATE AS OF CHANGE: 20151124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lismore Damian T. CENTRAL INDEX KEY: 0001560864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 151252578 MAIL ADDRESS: STREET 1: 12270 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-11-23 0001618561 Nexvet Biopharma plc NVET 0001560864 Lismore Damian T. C/O NEXVET BIOPHARMA PLC UNIT 5, SRAGH TECHNOLOGY PARK,RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 IRELAND 0 1 0 0 CHIEF FINANCIAL OFFICER Ordinary Shares 2015-11-23 4 M 0 6000 .125 A 16000 D Ordinary Shares 14160 I By spouse Ordinary Shares 13724 I Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C> Option to Purchase Shares .125 2015-11-23 4 M 0 6000 0 D 2019-07-01 Ordinary Shares 6000 8000 D The reporting person and his spouse share voting and dispositive power with respect to these reported securities. 6,000 options to purchase shares vested and became exercisable on 11/19/15 after the Issuer's board of directors determined that there had been successful completion of an efficacy trial for an Issuer product. A further 4,000 options to purchase shares will vest and become exercisable on each of 7/1/16 and 7/1/17. /s/ Damian Lismore by Geraldine T. Farrell, Attorney-in-Fact 2015-11-23